Bajaj Healthcare Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Sep 2025 is 11.14% vs 31.50% in Sep 2024

Standalone Net Profit

YoY Growth in quarter ended Sep 2025 is 17.44% vs 373.41% in Sep 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 9.82% vs 29.45% in Sep 2024

Interest

YoY Growth in quarter ended Sep 2025 is -29.44% vs -4.60% in Sep 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024

Compare Quarterly Results Of Bajaj Healthcare With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

147.91

83.94

63.97

76.21%

Other Operating Income

0.00

Total Operating income

147.91

83.94

63.97

76.21%

Raw Material Cost

74.81

36.23

38.58

106.49%

Purchase of Finished goods

0.00

2.63

-2.63

-100.00%

(Increase) / Decrease In Stocks

-1.20

3.05

-4.25

-139.34%

Employee Cost

16.51

17.23

-0.72

-4.18%

Power Cost

0.00

Manufacturing Expenses

-0.01

0.00

-0.01

Selling and Distribution Expenses

0.00

Other Expenses

30.86

18.14

12.72

70.12%

Total Expenditure (Excl Depreciation)

120.97

77.28

43.69

56.53%

Operating Profit (PBDIT) excl Other Income

26.94

6.66

20.28

304.50%

Other Income

1.65

2.49

-0.84

-33.73%

Operating Profit (PBDIT)

28.59

9.15

19.44

212.46%

Interest

5.56

2.53

3.03

119.76%

Exceptional Items

-1.34

4.66

-6.00

-128.76%

Gross Profit (PBDT)

23.03

11.28

11.75

104.17%

Depreciation

7.08

3.31

3.77

113.90%

Profit Before Tax

15.96

7.97

7.99

100.25%

Tax

3.51

-3.79

7.30

192.61%

Provisions and contingencies

0.00

Profit After Tax

12.45

11.76

0.69

5.87%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

-1.34

0.00

-1.34

Net Profit

11.11

11.76

-0.65

-5.53%

Equity Capital

15.79

38.21

-22.42

-58.68%

Face Value

5.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

3.52

0.31

3.21

1,035.48%

Diluted Earnings per share

3.47

0.31

3.16

1,019.35%

Operating Profit Margin (Excl OI)

18.21%

7.93%

0.00

10.28%

Gross Profit Margin

15.57%

13.44%

0.00

2.13%

PAT Margin

8.42%

14.01%

0.00

-5.59%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 147.91 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -0.62% vs -3.64% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 11.14% vs 31.50% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 11.11 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -6.09% vs 5.81% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 17.44% vs 373.41% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 26.94 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 9.87% vs 108.68% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 9.82% vs 29.45% in Sep 2024

Quarterly - Interest

Interest 5.56 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 6.31% vs -13.98% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -29.44% vs -4.60% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 18.21%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024